[Incidence of side effects of synthetic progestins with different content of estrogenic and gestagenic components].
D000328:Adult; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D004715:Endometriosis / Q000188:drug therapy*; D004997:Ethinyl Estradiol / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006908:Hydroxyprogesterones / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D008656:Mestranol / Q000009:adverse effects; D009641:Norethynodrel / Q000009:adverse effects; D045167:Progesterone Congeners / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D014594:Uterine Neoplasms / Q000188:drug therapy*
D004338:Drug Combinations; D006908:Hydroxyprogesterones; D045167:Progesterone Congeners; D004997:Ethinyl Estradiol; D009641:Norethynodrel; D008656:Mestranol
Chastota pobo chnykh reaktsiĭ na sinteticheskie progestiny s raznym soderzhaniem estrogennogo i gestagennogo komponentov.